This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

22 Jul 2011

Abbott Reports 2Q Financial Results

Abbott Laboratories reports its financial results for the second quarter 2011 with a 17 per cent rise in worldwide pharmaceutical sales.

Drug and medical device maker Abbott Laboratories reported Wednesday its financial results for the second quarter 2011.


Worldwide pharmaceutical sales increased 17% in the quarter to $4.1 billion, driven by Humira, Niaspan and Kaletra. Humira sales were $1.1 billion in the quarter (+48%), Niaspan sales were $194 million  (+14%) and Kaletra sales were $355 million (+13%). R&D expenses grew 13% to $657 million in the quarter. Pharmaceutical sales were $8.0 billion for the first half of the year (+16%). Humira sales reached nearly $2.0 billion in 1H08 (+51%).


2Q Revenues: $7.3 billion (+15%)

2Q Earnings: $1.3 billion (+34%)

YTD Revenues:

Related News